email [email protected]. Abstract:The ... protein nanocages, to generate a platform for the highly- ... automated applications, and analyze their advantages and.
Apr 15, 2002 - Ian M. Mackay,1,2,3 Kevin C. Jacob,1 Daniel Woolhouse,1 Katharine Waller,1. Melanie W. Syrmis,1 David M. Whiley,1 David J. Siebert,4.
Dec 5, 1988 - their newborn infants from a high-risk population for syphilis. ... newborn children with congenital syphilis were positive in the VDRL ELISA for ...
Correspondence should be addressed to Hans G. Heine; [email protected]. Received 19 October 2012; Accepted 25 December 2012. Academic Editor: ...
phosphate synthase (EPSPS) (EC 2.5.1.19) results in an starvation of EPSP and ensuing metabolic products, such as the aromatic amino acids phenylalanine, ...
2009;(17):2329â2331 with permission of The Royal Society of Chemistry. ..... Rife JC, Miller MM, Sheehan PE, Tamanaha CR, Tondra M, Whitman LJ.
Oct 4, 2013 - biopsies,â Virchows Archiv, vol. 460, no. 4, pp. 407â414, 2012. [9] G. Ellison, G. Zhu, A. Moulis, S. Dearden, G. Speake, and R. McCormack ...
Aug 17, 2015 - Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other.
AND JOHN A. STEWART1. Centers for Disease Control ..... Viviano, E., F. Vitale, F. Ajello, A. M. Perna, M. R. Villafrate, F. Bonura, M. Arico, A. Mazzola, and N.
Jul 2, 2010 - medium, provided the original work is properly cited. Research ... Jack Groskopf1, Harry G Rittenhouse1, Robert L Vessella2,3 and Mark A Reynolds*1. Abstract .... The C4-2 prostate cancer cell line [25] was a gift from ...... Attard G,
Burans J., Morgan C., Meyer H. (2000): Field detection of Francisella tularensis. Scandinavian Journal of In- fectious Diseases, 32, 287â291. Bevanger L.
Nov 9, 2013 - School of Pathology, University of the Witwatersrand, Johannesburg, South Africad; Division of ...... labs, which has the potential to introduce bias if laboratory tech- .... Bang D, Andersen PH, Andersen AB, Thomsen VO. 2010.
Feb 2, 2011 - Vic Veguilla,1 Kathy Hancock,1 Jarad Schiffer,2 Paul Gargiullo,1 ..... nical assistance, respectively; George Carlone and Sandra Steiner for.
Dec 3, 2010 - rating Center, at the Institut Pasteur (Paris, France). We also included clinical strains (n. 91) isolated from human and animals of different ...
able a cure of an individual patient but will reduce future numbers of TB cases [4]. ...... Aubry A, Sougakoff W, Bodzongo P, Delcroix G, Armand S, Millot G, et al.
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2004, p. 5189â ... Virology, University Medical Centre Rotterdam, Rotterdam, The Netherlands2. Received 15 ...
sprayed per plant onto either soybean or red kidney leaves with an atomizer ... Plants inoculated with different P. pachyrhizi and P. meibomiae isolates were ... to a power drill. Samples were ... C. Levy, Turk Mine ...... John Wiley & Sons, New York
Mar 23, 2015 - ... Department of Paediatrics at the Royal Children's Hospital, Parkville, ...... O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall ...
Sep 11, 2015 - addition, using a WHO-Chinese National Influenza Center (CNIC) method as a reference ... Data Availability Statement: All relevant data are ... cient number of clinical specimens collected throughout the major epidemic regions of China
Apr 11, 2001 - pSCAx, pSCA, pSCA-K8.1A, pSCA-orf73, and pSCA-Helper were described previously (14). pSCA-orf65 was constructed by PCR amplifica-.
We evaluated the performances of 4 commercial real-time PCR kits for Bordetella pertussis IS481 sequence detection in nasopharyngeal aspirates by ...
Mycoplasma pneumoniae accounts for approximately 15% to. 20% of all community-acquired pneumonia cases and is a com- mon cause of outbreaks (10, 16, ...
Oct 22, 1998 - diagnosis of cervical neoplastic lesions, assays that detect HPV. DNA in cervical .... for use in the diagnostic microbiology laboratory for routine.
Click-it® Detection assays. Comparison to Traditional Detection Technologies. Introduction. Life Technologies is committed to designing products with the.
Green features
Fact Sheet
Click-iT® Detection Assays Comparison to Traditional Detection Technologies
Green Benefits • Alternative to radioisotopes—enables you to eliminate the exposure, handling, storage, and disposal of radioactive materials from your laboratory
Introduction Life Technologies is committed to designing products with the environment in mind—it’s one more step toward a smaller footprint. This fact sheet provides the rationale behind the environmental claim that the Click-iT® detection assays are less hazardous than other common methods of detecting cell proliferation and protein synthesis. The use of Click-iT® detection assays provides an alternative to exposure to radiation for performing common cellular and biochemical analyses, including detection of cell proliferation and monitoring of protein synthesis and metabolism using the isotopes 3 H-thymidine and 35S-methionine, respectively. The novel chemistries developed for Click-iT® assays enable detection at sensitivity similar to that of radioactivity, without requiring the use of radioisotopes.
Green Features Less Hazardous Traditional technologies for in vivo and in vitro labeling of nucleic acids, protein/peptides, and other small biomolecules utilizes radioactive tracers. In addition to the inherent physical and biological hazards associated with the use of radioactivity, regulatory management activities are intensive and waste storage and/or disposal costs are very high. Click-iT® detection assays provide an alternative to the use of radioactivity, thereby eliminating the need for radioactive licenses, and such burdensome regulatory requirements as reporting, recordkeeping, medical surveillance, shielding, and special disposal requirements. Please see the MSDSs for this line of products at www.invitrogen.com/msds.
Product Description Click-iT® technology supports in vivo and in vitro labeling of nucleic acids, proteins/peptides, and other small biomolecules for monitoring biological viability and activity.
